NCT02859402
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Dong-A University Busan, South Korea
- Keimyung University Dongsan Medical Center Daegu, South Korea
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
185 public trials
53 recruiting studies
Lymphoma, T-Cell trial results
NCT03161223
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT03869619
- Conditions
- Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
- Locations
-
- Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
- Service d'Hématologie, CHU Jean Minjoz Besançon, France
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Institut Bergonié Bordeaux, France
Not yet recruiting
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
NCT07691450
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +36 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Not yet recruiting
A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.
NCT07657572
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
Not specified
Not yet recruiting
Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
NCT07538960
- Conditions
- Cutaneous, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Hospital México San José, Uruca, Costa Rica
Not yet recruiting
EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas
NCT07339527
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified
Not yet recruiting
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
NCT07117305
- Conditions
- CD7+ Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China
Enrolling by invitation
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
NCT03628612
- Conditions
- ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- University of Miami Miami, Florida, United States
- Washington University in St. Louis St Louis, Missouri, United States
- St David's South Austin Medical Center Austin, Texas, United States
- Queen Elizabeth University Hospital Glasgow, United Kingdom
Enrolling by invitation
A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
NCT07784309
- Conditions
- Acute Myeloid Leukemia (AML), Acute T Cell Lymphoblastic Leukemia, Hematologic Diseases, +18 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China